The current valuation score of MeiraGTx Holdings PLC is 9.46, ranking 17 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -7.95, which is -81.79% below the recent high of -1.45 and -24.34% above the recent low of -9.88.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.